Product Images Glycopyrrolate

This is a description of a prescription medication called Glycopyrrolate injection, USP that is available in a single-dose vial of 1 mL. The concentration of the medication is 0.2 mg per mL and it contains Benzyl Alcohol. It can be used for intramuscular or intravenous administration. The manufacturer is Meitheal Pharmaceuticals based in Chicago, USA with the code of TN/Drugs/TN00003457. It also includes a lot number as NUvZ and an expiration date of 16.5x7mm.*

Glycopyrrolate is an injection medication that is only available through a prescription, and is produced by Meitheal Pharmaceuticas in Chicago, USA. Each vial contains 0.4 mg of medication in 2 ml of solution or 0.2mg/ml. The product is identified by the code TN/Drugs/TN00003457, and the NDC number 71288-407-02. This medication contains Benzyl Alcohol and is intended for intramuscular or intravenous use. The vial is single-dose with an expiration date of 15.5mm x 6.5mm.*

Glycopyrrolate Injection is an intravenous or intramuscular medication used to treat various conditions. It comes in a multi-dose vial of 5 mL, with a strength of 1 mg per 3 ml. The medication should not be used in newborns. The product contains benzyl alcohol and should be adjusted as needed with hydrochloric acid and/or sodium hydroxide. The typical dosage should be determined by accompanying descriptive literature. The NDC number for the product is NDC71288-408-05, and it is manufactured by Meitheal Pharmaceuticals.*

This is a prescription drug with the name Glycopyrrolate manufactured by Meitheal Pharmaceuticals. It is available in a multi-dose vial and is used for injection purposes only. It is not suitable for use in newborns, and it contains Benzyl Alcohol. The vial has a code for identification purposes. The dosage strength is 0.2mg per ml. The text also mentions the manufacturer's address in Chicago.*

Not available. The text seems to be a mix of measurements and characters that cannot be interpreted.*